Schizophrenia Clinical Trial
Official title:
OnTrack>An Online Role-Playing Game: A Small Business Innovation Research (SBIR) Grant
Our team will develop a prototype game (OnTrack>The Game) in which users play the role of a
person who has experienced First Episode Psychosis and move through animated role-playing
scenarios, learning practical tips for engaging in care, playing mini-games to develop self-
advocacy skills, and seeing stories of hope and recovery (brief video vignettes). The game
is designed in an engaging comic book style in which the player is presented with realistic
situations designed to promote engagement and the development of trusting relationships.
Following development of the prototype, the investigators will conduct a pilot study to
develop preliminary data to determine feasibility of a large-scale Phase 2 effectiveness
study. This pilot study aims to demonstrate proof of concept for OnTrack>The Game. The
investigators will recruit a sample of patients/consumers (n=25) from OnTrackNY sites that
offer services for those experiencing their first psychotic episode. Quantitative data will
be collected through baseline and follow up surveys that utilize instruments to measure
knowledge and attitudes about recovery, perceptions of stigma, feelings of empowerment and
sense of hopefulness. The investigators will also conduct semi-structured interviews with a
subset of participants to explore engagement in treatment and attitudes toward the game.
In light of research supporting early first episode psychosis (FEP) intervention models as
well as the efficacy of video gaming to engage young people with FEP in treatment, the
connection between the two needs to be explored. A gaming tool for first-episode psychosis
has the potential to improve patient care; and, decrease stigma associated with
schizophrenia.
Hypothesis:
The investigators hypothesize that Phase 1 of this study will demonstrate that the videogame
is comprehensible, engaging and easy to maneuver. The investigators hypothesize that the
results from the pilot study will suggest that this technologically innovative tool has
potential to enhance positive outcomes of research-tested interventions, such as OnTrackNY,
for individuals with FEP.
Approach:
Our team will develop a prototype game (OnTrack>The Game) in which users play the role of a
person who has experienced FEP and move through animated role-playing scenarios, learning
practical tips for engaging in care, playing mini-games to develop self- advocacy skills,
and seeing stories of hope and recovery (brief video vignettes). The game is designed in an
engaging comic book style in which the player is presented with realistic situations
designed to promote engagement and the development of trusting relationships.
Following development of the prototype, the investigators will conduct a pilot study to
develop preliminary data to determine feasibility of a large-scale Phase 2 effectiveness
study. This pilot study aims to demonstrate proof of concept for OnTrack>The Game. The
investigators will recruit a sample of patients/consumers (n=25) from OnTrackNY sites that
offer services for those experiencing their first psychotic episode. Quantitative data will
be collected through baseline and follow up surveys that utilize instruments to measure
knowledge and attitudes about recovery, perceptions of stigma, feelings of empowerment and
sense of hopefulness. The investigators will also conduct semi-structured interviews with a
subset of participants to explore engagement in treatment and attitudes toward the game.
;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
| Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
| Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
| Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
| Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
| Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
| Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
| Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
| Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
| Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
| Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
| Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
| Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
| Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
| Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
| Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
| Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
| Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
| Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |